Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Weigel

Showing results (221-230 of 423) with videos related to

Pageof 43
Sort By:
Surgery|October 18, 2011
Sampling of secondary margins decreases the need for re-excision after partial mastectomyJulie A Guidroz, Gregory Larrieux, Junlin Liao, et al.
Surgery|August 12, 2018
Risk factors for 30-day readmission after adrenalectomyAnna C Beck, Paolo Goffredo, Imran Hassan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1982
Development of polyamine and biogenic amine systems in brains and hearts of neonatal rats given dexamethasone: role of biochemical alterations in cellular maturation for producing deficits in ontogeny of neurotransmitter levels, uptake, storage and turnoverT A Slotkin, G Barnes, C Lau, et al.
Annals of Surgical Oncology|June 13, 2009
Extracellular matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: a Hospital-based Cohort Study in IowaGeeta Lal, Samad Hashimi, Brian J Smith, et al.
Nucleic Acids Research|March 23, 2011
Discovery of SMAD4 promoters, transcription factor binding sites and deletions in juvenile polyposis patientsDaniel Calva, Fadi S Dahdaleh, George Woodfield, et al.
American Journal of Surgery|December 4, 2009
The use of touch preparation for the evaluation of sentinel lymph nodes in breast cancerJulie A Guidroz, Matthew T Johnson, Carol E H Scott-Conner, et al.
Pediatric Blood & Cancer|January 3, 2018
Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)Robin E Norris, Elizabeth Fox, Joel M Reid, et al.
Annals of Surgical Oncology|May 28, 2009
When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?Daniel Calva, Thomas M O'Dorisio, M Sue O'Dorisio, et al.
Journal of Inherited Metabolic Disease|March 7, 2012
Tetrahydrobiopterin (BH4) in PKU: effect on dietary treatment, metabolic control, and quality of lifeB Ziesch, J Weigel, A Thiele, et al.
FEBS Open Bio|April 9, 2015
Design and evaluation of a peptide-based immunotoxin for breast cancer therapeuticsKelsey J Weigel, Luqun Shen, Clayton L Thomas, et al.
Pageof 43

Showing results (221-230 of 423) with videos related to

Sort By:
Pageof 43
Surgery|October 18, 2011
Sampling of secondary margins decreases the need for re-excision after partial mastectomyJulie A Guidroz, Gregory Larrieux, Junlin Liao, et al.
Surgery|August 12, 2018
Risk factors for 30-day readmission after adrenalectomyAnna C Beck, Paolo Goffredo, Imran Hassan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1982
Development of polyamine and biogenic amine systems in brains and hearts of neonatal rats given dexamethasone: role of biochemical alterations in cellular maturation for producing deficits in ontogeny of neurotransmitter levels, uptake, storage and turnoverT A Slotkin, G Barnes, C Lau, et al.
Annals of Surgical Oncology|June 13, 2009
Extracellular matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: a Hospital-based Cohort Study in IowaGeeta Lal, Samad Hashimi, Brian J Smith, et al.
Nucleic Acids Research|March 23, 2011
Discovery of SMAD4 promoters, transcription factor binding sites and deletions in juvenile polyposis patientsDaniel Calva, Fadi S Dahdaleh, George Woodfield, et al.
American Journal of Surgery|December 4, 2009
The use of touch preparation for the evaluation of sentinel lymph nodes in breast cancerJulie A Guidroz, Matthew T Johnson, Carol E H Scott-Conner, et al.
Pediatric Blood & Cancer|January 3, 2018
Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)Robin E Norris, Elizabeth Fox, Joel M Reid, et al.
Annals of Surgical Oncology|May 28, 2009
When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?Daniel Calva, Thomas M O'Dorisio, M Sue O'Dorisio, et al.
Journal of Inherited Metabolic Disease|March 7, 2012
Tetrahydrobiopterin (BH4) in PKU: effect on dietary treatment, metabolic control, and quality of lifeB Ziesch, J Weigel, A Thiele, et al.
FEBS Open Bio|April 9, 2015
Design and evaluation of a peptide-based immunotoxin for breast cancer therapeuticsKelsey J Weigel, Luqun Shen, Clayton L Thomas, et al.
Pageof 43